Skip to main content

Table 2 Baseline demographic and clinical characteristics of concept elicitation and cognitive interview participants

From: Development of the Fabry Disease Patient-Reported Outcome (FD-PRO): a new instrument to measure the symptoms and impacts of Fabry Disease

Characteristic

Concept elicitation participants

Cognitive interview participants

Treated group (n = 20)

Treatment-naïve group (n = 17)

All (N = 37)

All (N = 14)

Age (years), mean ± SD

45.7 ± 12.1

43.7 ± 13.8

45.7 ± 12.9

48.9 ± 15.8

Female, n (%)

11 (55.0)

11 (64.7)

22 (59.5)

8 (53)

Phenotype

 

 Classic, n (%)

19 (95.0)

15 (88.2)

34 (91.9)

N/A

 Late-onset, n (%)

1 (5.0)

2 (11.8)

3 (0.1)

N/A

Marital status, n (%)

 

 Married/living as married

14 (70.0)

11 (64.7)

25 (67.6)

5 (36)

 Widowed

0

1 (5.9)

1 (2.7)

2 (14)

 Separated/divorced

2 (10.0)

1 (5.9)

3 (8.1)

4 (29)

 Never married

4 (20.0)

4 (23.5)

8 (21.6)

3 (21)

Post-secondary education, n (%)

13 (65.0)

13 (76.5)

26 (70.2)

12 (86)

Employment status, n (%)

 

 Employed full-time, part-time, self-employed

13 (65.0)

12 (70.6)

25 (67.6)

7 (50)

 Out of work

1 (5.0)

2 (11.8)

3 (8.1)

2 (14)

 Homemaker

1 (5.0)

1 (5.9)

2 (5.4)

2 (14)

 Retired

1 (5.0)

2 (11.8)

3 (8.1)

1 (7)

 Unable to work

4 (20.0)

0

4 (10.8)

2 (14)

Race, n (%)

 

 White

15 (88.2)

17 (85.0)

32 (86.5)

14 (100)

 Black

2 (11.8)

2 (10.0)

4 (10.8)

0

 Other

0

1 (5.0)

1 (2.7)

0

Hispanic, Latino, or Spanish origin, n (%)

2 (11.8)

1 (5.0)

3 (8.1)

0

Time since diagnosis, years, mean ± SD

14.5 ± 13.7

3.6 ± 7.6

9.6 ± 12.3

12.0 ± 9.6

Time since confirming genetic test, years, mean ± SD

11.3 ± 13.7

2.5 ± 3.4

7.4 ± 10.9

N/A

Treated with ERT ≥ 3 years, n (%)

12 (60.0)

0

12 (32.4)

N/A

Ever received treatment (Replagal, SRT, or Fabrazyme

N/A

N/A

N/A

12 (86)

Treated with Fabrazyme ≥ 6 months, n (%)

N/A

N/A

N/A

11 (79)

  1. CE concept elicitation, ERT enzyme replacement therapy, N/A not applicable, SD standard deviation